AB1064 No clinically meaningful drug interactions expected between lesinurad, a novel oral uricosuric agent, and drugs most commonly used by gout patients

Abstract

BackgroundLesinurad is a novel URAT1 inhibitor that has been well tolerated in humans, with dose-dependent reductions of serum urate (sUA). In vitro experiments and in vivo human absorption, metabolism, and...